SPARTALIZUMAB

UNII:	QOG25L6Z8Z
Formula:
Preferred Substance Name:	SPARTALIZUMAB

1935694-88-4
ANTI-PD1 MONOCLONAL ANTIBODY PDR001
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1)(HUMAN-MUS MUSCULUS MONOCLONAL CLONE NVS240118 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL CLONE NVS240118 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS PROGRAMMED CELL DEATH PROTEIN 1 (PROTEIN PD-1, CD-279 ANTIGEN))HUMANIZED MONOCLONAL ANTIBODY.GAMMA.4 HEAVY CHAIN (1-443) (HUMANIZED VH (HOMO SAPIENS IGHV1-69-2*01 (75%) (IGHD)-IGHJ6*01) (8.8.10) (1-117)-HOMO SAPIENS IGHG4*01 (HINGE(S10>P(225)), CH3(K107>DEL(444))) (118-443)) (131-220')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-220') (HUMANIZED V-KAPPA (HOMO SAPIENS IGKV3D-11*03 (76%) IGKJ1*01 (92%))(12.3.9) (1'-113')-HOMO SAPIENS IGKC*01 (114'-220')), DIMER (223-223'':226-226'')-BISDISULFIDE
NVP-LZV184
PDR001
PDR-001
SPARTALIZUMAB [INN]
SPARTALIZUMAB [JAN]
SPARTALIZUMAB [USAN]
SPARTALIZUMAB [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

SPARTALIZUMAB

Synonyms and Mappings

Resources